Ticagrelor: the first novel reversible P2Y₁₂ inhibitorHTUN, Wah Wah; STEINHUBL, Steven R.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 2, pp 237-245, issn 1465-6566, 9 p.Article

Clinical efficacy of clopidogrel across the whole spectrum of indications : percutaneous coronary interventionHAMDALLA, Hussam; STEINHUBL, Steven R.European heart journal supplements. 2006, Vol 8G, issn 1520-765X, G20-G24Article

Clopidogrel and coronary stenting: What is the next question?MOORE, Scott A; STEINHUBL, Steven R.Journal of thrombosis and thrombolysis. 2000, Vol 10, Num 2, pp 121-126, issn 0929-5305Article

Antiplatelet medications and their indications in preventing and treating coronary thrombosisVAN DE GRAAFF, Eric; STEINHUBL, Steven R.Annals of medicine (Helsinki). 2000, Vol 32, Num 8, pp 561-571, issn 0785-3890Article

Novel Wireless Devices for Cardiac MonitoringWALSH, Joseph A; TOPOL, Eric J; STEINHUBL, Steven R et al.Circulation (New York, N.Y.). 2014, Vol 130, Num 7, pp 573-581, issn 0009-7322, 9 p.Article

Why Have Antioxidants Failed in Clinical Trials?STEINHUBL, Steven R.The American journal of cardiology. 2008, Vol 101, Num 10, issn 0002-9149, 14D-19D, SUPArticle

Aspirin dose for the prevention of cardiovascular disease : A systematic reviewCAMPBELL, Charles L; SMYTH, Susan; MONTALESCOT, Gilles et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 18, pp 2018-2024, issn 0098-7484, 7 p.Article

High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent mannerOESTREICH, Julie H; STEINHUBL, Steven R; FERRARIS, Suellen P et al.Thrombosis and haemostasis. 2011, Vol 105, Num 5, pp 927-930, issn 0340-6245, 4 p.Article

Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients Initial Evidence of a Therapeutic WindowSIBBING, Dirk; STEINHUBL, Steven R; SCHULZ, Stefanie et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 4, pp 317-318, issn 0735-1097, 2 p.Article

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trialCOLLET, Jean-Philippe; MONTALESCOT, Gilles; GABRIEL STEG, Philippe et al.Archives of cardiovascular diseases. 2009, Vol 102, Num 6-7, pp 485-496, issn 1875-2136, 12 p.Article

Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor useSABATINE, Marc S; HAMDALLA, Hussam N; MEHTA, Shamir R et al.The American heart journal. 2008, Vol 155, Num 5, pp 910-917, issn 0002-8703, 8 p.Article

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the DCHARISMA trial. CommentarySEREBRUANY, Victor L; WANG, Thomas H; STEG, P. Gabriel et al.European heart journal. 2007, Vol 28, Num 18, issn 0195-668X, 2183-2184, 2200-2207 [10 p.]Article

Time to Coronary Angiography and Outcomes Among Patients With High-Risk Non-ST-Segment-Elevation Acute Coronary Syndromes : Results From the SYNERGY TrialTRICOCI, Pierluigi; LOKHNYGINA, Yuliya; FERGUSON, James J et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 23, pp 2669-2677, issn 0009-7322, 9 p.Article

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsBHATT, Deepak L; FOX, Keith A. A; FLATHER, Marcus D et al.The New England journal of medicine. 2006, Vol 354, Num 16, pp 1706-1717, issn 0028-4793, 12 p.Article

Onset and offset of platelet inhibition after high-dose Clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteersPRICE, Matthew J; COLEMAN, Jacqueline L; STEINHUBL, Steven R et al.The American journal of cardiology. 2006, Vol 98, Num 5, pp 681-684, issn 0002-9149, 4 p.Article

Variability in platelet responsiveness to clopidogrel among 544 individualsSEREBRUANY, Victor L; STEINHUBL, Steven R; BERGER, Peter B et al.Journal of the American College of Cardiology. 2005, Vol 45, Num 2, pp 246-251, issn 0735-1097, 6 p.Article

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: The Plavix Use for Treatment of Congestive Heart Failure (PLUTO-CHF) trialSEREBRUANY, Victor L; MALININ, Alex I; JEROME, Scott D et al.The American heart journal. 2003, Vol 146, Num 4, pp 713-720, issn 0002-8703, 8 p.Article

Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation modelFOLEY, Joseph D; DARRELL SNEED, J; STEINHUBL, Steven R et al.Oral surgery, oral medicine, oral pathology and oral radiology (Print). 2012, Vol 114, Num 5, pp 616-623, issn 2212-4403, 8 p.Article

The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic diseaseMAK, Koon-Hou; BHATT, Deepak L; FOX, Keith A. A et al.European heart journal. 2009, Vol 30, Num 7, pp 857-865, issn 0195-668X, 9 p.Article

Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular DiseaseBERGER, Jeffrey S; BHATT, Deepak L; BERGER, Peter B et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 23, pp 2337-2344, issn 0009-7322, 8 p.Article

Transitioning patients from cangrelor to clopidogrel : Pharmacodynamic evidence of a competitive effectSTEINHUBL, Steven R; OH, Jennifer J; OESTREICH, Julie H et al.Thrombosis research. 2008, Vol 121, Num 4, pp 527-534, issn 0049-3848, 8 p.Article

The Ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapyWHEELER, Guy L; BRADEN, Gregory A; STEINHUBL, Steven R et al.The American heart journal. 2002, Vol 143, Num 4, pp 602-611, issn 0002-8703Article

Usefulness of the response to sublingual nitroglycerin as a predictor of ischemic chest pain in the emergency departmentSHRY, Eric A; DACUS, Jennifer; VAN DE GRAAFF, Eric et al.The American journal of cardiology. 2002, Vol 90, Num 11, pp 1264-1266, issn 0002-9149, 3 p.Article

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variableCASTERELLA, Peter J; KEREIAKES, Dean J; STEINHUBL, Steven R et al.Catheterization and cardiovascular interventions. 2001, Vol 54, Num 4, pp 497-504, issn 1522-1946Article

Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialCAIXETA, Adriano; DANGAS, George D; MAGNUS OHMAN, E et al.The American heart journal. 2011, Vol 161, Num 2, pp 298-306, issn 0002-8703, 9 p.Article